Clinical trial
DHEA Treatment for Sjogren's Syndrome
NCT00001598 · National Institute of Dental and Craniofacial Research (NIDCR), NIH · Completed
Key facts
| NCT number | NCT00001598 |
|---|---|
| Title | DHEA Treatment for Sjogren's Syndrome |
| Official title | Dehydroepiandrosterone (DHEA) Treatment for Sjogren's Syndrome |
| Lead sponsor | National Institute of Dental and Craniofacial Research (NIDCR), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lacrimal Apparatus Disease, Salivary Gland Disease, Sjogren's Syndrome, Xerostomia |
| Intervention type | Drug |
| Interventions | Dehydroepiandrosterone |
| Enrollment | 28 |
| Start date | May 1, 1997 |
| Completion | Jun 1, 2002 |
| First posted | Nov 4, 1999 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: